Concepedia

Publication | Closed Access

SC-54684A: An Orally Active Inhibitor of Platelet Aggregation

65

Citations

29

References

1995

Year

Abstract

SC-54684A, an orally active antiplatelet drug now in clinical trial, is shown to be a potent, specific fibrinogen binding inhibitor that blocks platelet aggregation to a wide variety of known stimuli and has good bioavailability in animals.

References

YearCitations

1990

1.6K

1971

1.5K

1986

934

1979

711

1985

590

1989

554

1988

515

1991

350

1987

263

1987

262

Page 1